Abstract Details
Katherine G. Meilleur, PhD, PPCNP-BC
(National Institutes of Health)
PRESENTER |
No disclosure on file |
No disclosure on file | |
Jessica Witherspoon | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Jeff Elliott | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Tanya J. Lehky, MD (National Institutes of Health) | Dr. Lehky has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
James Dowling, MD, PhD (Hospital for Sick Children) | Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ikaika Therapeutics. Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bain Consulting. Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RYR1 Foundation. Dr. Dowling has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Dechert LLP. The institution of Dr. Dowling has received research support from Astellas. The institution of Dr. Dowling has received research support from NIH. The institution of Dr. Dowling has received research support from CIHR. The institution of Dr. Dowling has received research support from Astellas. Dr. Dowling has received personal compensation in the range of $5,000-$9,999 for serving as a advisor with Ontario Ministry of Health. |
Carsten G. Bonnemann, MD | Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with RYR1 Foundation that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Genethon that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Sarepta Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Kate Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with CureCMD that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Seal Therapeutics that is relevant to AAN interests or activities. |
No disclosure on file |